tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Midday Fly By: Trump threatens China tariffs, Kalshi valued at $5B
PremiumThe FlyMidday Fly By: Trump threatens China tariffs, Kalshi valued at $5B
12d ago
Protagonist Therapeutics resumes, up 28% after report of J&J takeover talks
Premium
The Fly
Protagonist Therapeutics resumes, up 28% after report of J&J takeover talks
12d ago
Protagonist Therapeutics trading resumes
Premium
The Fly
Protagonist Therapeutics trading resumes
12d ago
Protagonist Therapeutics participates in a conference call with JPMorgan
PremiumThe FlyProtagonist Therapeutics participates in a conference call with JPMorgan
12d ago
Protagonist Therapeutics’ Icotrokinra: A Promising Blockbuster Candidate with Broad Therapeutic Potential
Premium
Ratings
Protagonist Therapeutics’ Icotrokinra: A Promising Blockbuster Candidate with Broad Therapeutic Potential
14d ago
Protagonist Therapeutics’ Icotrokinra: Promising Phase 2b Results Reinforce Buy Rating
Premium
Ratings
Protagonist Therapeutics’ Icotrokinra: Promising Phase 2b Results Reinforce Buy Rating
14d ago
Protagonist Therapeutics initiated with an Overweight at Barclays
PremiumThe FlyProtagonist Therapeutics initiated with an Overweight at Barclays
1M ago
Protagonist Therapeutics initiated with an Overweight at Barclays
Premium
The Fly
Protagonist Therapeutics initiated with an Overweight at Barclays
1M ago
Protagonist Therapeutics: Promising Phase 2b Results and Strong Safety Profile Justify Buy Rating
Premium
Ratings
Protagonist Therapeutics: Promising Phase 2b Results and Strong Safety Profile Justify Buy Rating
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100